| NDC Number | Brand Name | Generic Name | Manufacturer | Dosage Form | DEA Sch. | Marketing Start Date |
|---|---|---|---|---|---|---|
| 66658-501 | GAMIFANT | emapalumab-lzsg | Swedish Orphan Biovitrum AB (publ) | INJECTION | 2019-05-17 | |
| 66658-505 | GAMIFANT | emapalumab-lzsg | Swedish Orphan Biovitrum AB (publ) | INJECTION | 2019-05-17 | |
| 66658-510 | GAMIFANT | emapalumab-lzsg | Swedish Orphan Biovitrum AB (publ) | INJECTION | 2020-06-26 | |
| 66658-522 | GAMIFANT | emapalumab-lzsg | Swedish Orphan Biovitrum AB (publ) | INJECTION | 2023-06-07 | |
| 66658-523 | GAMIFANT | emapalumab-lzsg | Swedish Orphan Biovitrum AB (publ) | INJECTION | 2023-06-07 | |
| 66658-524 | GAMIFANT | emapalumab-lzsg | Swedish Orphan Biovitrum AB (publ) | INJECTION | 2023-06-07 | |
| 66658-525 | GAMIFANT | emapalumab-lzsg | Swedish Orphan Biovitrum AB (publ) | INJECTION | 2023-06-07 |
Loading full table content...